Related Experiment Video
Updated: Oct 4, 2025

Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
Ticagrelor after Acute Coronary Syndrome: One For All or Part of Personalized Medicine?
Ibrahim Akin1, Christoph A Nienaber2
1Universitätsmedizin Mannheim; Theodor-Kutzer Ufer 1-3; 68167 Mannheim, Germany; DZHK (Deutsches Zentrum für Herz-Kreislaufforschung) Partner Site Mannheim.
No abstract available in PubMed .
More Related Videos
10:28Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Acute Coronary Syndrome IV: Interprofessional Care
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...